Beneficial effect of treatment with a monoclonal anti-tumor necrosis factor-alpha antibody on markers of coagulation and fibrinolysis in patients with active Crohn's disease.

Source:http://linkedlifedata.com/resource/pubmed/id/9731107

Download in:

View as

General Info

PMID
9731107